FDA Approves Botox for Migraine

By Teri Robert, Health Guide Sunday, October 17, 2010

- A
- A
- A

The FDA has now approved Botox (onabotulinumtoxinA) for the treatment of chronic Migraine. Russell Katz, M.D., director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research, stated,

"Chronic migraine is one of the most disabling forms of headache. Patients with chronic migraine experience a headache more than 14 days of the month. This condition can greatly affect family, work, and social life, so it is important to have a variety of effective treatment options available.

For more information, please see FDA Approves Botox for Migraine.

Live well,

Get the latest Migraine and headache news, informational articles, tips for living well, and more in my free weekly newsletter. To subscribe, CLICK HERE.

Follow me on or

Migraine and TIA: Understanding TIA

Be the first to comment

Related Migraine Topics

By Teri Robert, Health Guide— Last Modified: 10/17/10, First Published: 10/17/10

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

FDA Approves Botox for Migraine

Ask a Question